Monografie
Genetic causes and molecular mechanisms of autosomal dominant antibody deficiencies
- Sprache
-
Englisch
- Umfang
-
127 Seiten
- Identifier
-
1142145352
Thema
Immunologie; Immunsystem; Lymphozyt; Leukozyt; Immunität; Resistenz; Immunchemie; Hochschulschrift
Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2024, 08:52 MESZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Generation of a LPS specific recombinant antibody by antibody phage display for detection of L. pneumophila
Identification of molecular mediators controlling thymic regulatory T cells development and stability of Foxp3 expression
Role of CD4+ T cells and CD14+ myeloid cells for sustained effector functions of human cytokine-activated natural killer cells
Molecular and behavioral pharmacology of Gi-coupled receptors of the immune system
Generation of chimeric antigen receptors based on the T cell receptor-like monoclonal antibody TÜ165 for the control of Epstein-Barr virus associated tumors
Identification of regulatory mechanisms controlling signal processing in erythroid progenitor cells using mathematical modeling
Characterization of the Purkinje cell to nuclear cell connections in mice cerebellum
Development of mass spectrometry methodology for direct identification of viral epitopes from MHC I molecules
LYN-dependent intrinsic functions of malignant B cells
Antigen-specific recognition of commensal derived recombinant antigens via regulatory and effectory T cells
Novel yeast display based screening technologies for the generation of tailor-made human antibodies
Extracorporeal photopheresis: selective immuno-modulation of immune system without impairment of anti-viral and anti-leukemic effects
Generation of a LPS specific recombinant antibody by antibody phage display for detection of L. pneumophila
Identification of molecular mediators controlling thymic regulatory T cells development and stability of Foxp3 expression
Role of CD4+ T cells and CD14+ myeloid cells for sustained effector functions of human cytokine-activated natural killer cells
Molecular and behavioral pharmacology of Gi-coupled receptors of the immune system
Generation of chimeric antigen receptors based on the T cell receptor-like monoclonal antibody TÜ165 for the control of Epstein-Barr virus associated tumors
Identification of regulatory mechanisms controlling signal processing in erythroid progenitor cells using mathematical modeling
Characterization of the Purkinje cell to nuclear cell connections in mice cerebellum
Development of mass spectrometry methodology for direct identification of viral epitopes from MHC I molecules
LYN-dependent intrinsic functions of malignant B cells
Antigen-specific recognition of commensal derived recombinant antigens via regulatory and effectory T cells
Novel yeast display based screening technologies for the generation of tailor-made human antibodies
Extracorporeal photopheresis: selective immuno-modulation of immune system without impairment of anti-viral and anti-leukemic effects
Generation of a LPS specific recombinant antibody by antibody phage display for detection of L. pneumophila
Identification of molecular mediators controlling thymic regulatory T cells development and stability of Foxp3 expression
Role of CD4+ T cells and CD14+ myeloid cells for sustained effector functions of human cytokine-activated natural killer cells
Molecular and behavioral pharmacology of Gi-coupled receptors of the immune system
Generation of chimeric antigen receptors based on the T cell receptor-like monoclonal antibody TÜ165 for the control of Epstein-Barr virus associated tumors
Identification of regulatory mechanisms controlling signal processing in erythroid progenitor cells using mathematical modeling
Characterization of the Purkinje cell to nuclear cell connections in mice cerebellum
Development of mass spectrometry methodology for direct identification of viral epitopes from MHC I molecules
LYN-dependent intrinsic functions of malignant B cells
Antigen-specific recognition of commensal derived recombinant antigens via regulatory and effectory T cells
Novel yeast display based screening technologies for the generation of tailor-made human antibodies